Price Alert

IRadimed Corporation (IRMD)

NASDAQ: IRMD · Real-Time Price · USD

70.19

0.04 (0.06%)

At close: Aug 15, 2025, 3:59 PM

70.38

0.27%

After-hours: Aug 15, 2025, 04:10 PM EDT

IRadimed Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	77.64M	75.15M	73.24M	71.31M	69.48M	67.69M	65.56M	62.97M	59.88M	56.47M	53.3M	50.31M	47.81M	44.9M	41.81M	38.49M	35.28M	32.26M
Cost of Revenue	17.88M	17.35M	16.89M	16.3M	15.84M	15.86M	15.4M	15.01M	14.21M	12.84M	12.02M	11M	10.64M	10.53M	9.76M	9.25M	8.7M	8.09M
Gross Profit	59.75M	57.8M	56.35M	55M	53.65M	51.82M	50.16M	47.97M	45.67M	43.62M	41.28M	39.31M	37.17M	34.37M	32.05M	29.24M	26.58M	24.17M
Operating Income	23.81M	22.65M	21.96M	21.32M	21.44M	20.78M	20.04M	19.13M	17.36M	16.56M	15.63M	14.48M	13.44M	11.12M	9.82M	7.36M	5.06M	283.68K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	26.04M	24.98M	24.28M	23.61M	23.6M	22.63M	21.74M	20.76M	18.59M	17.47M	16.18M	14.59M	13.45M	11.12M	9.84M	7.39M	5.09M	318.73K
Net Income	20.66M	19.78M	19.23M	18.63M	18.64M	17.92M	17.19M	16.33M	14.69M	13.75M	12.83M	13.05M	12.2M	10.43M	9.33M	6.07M	4.57M	986.64K
Selling & General & Admin	33.23M	32.52M	31.55M	30.77M	29.48M	28.16M	27.26M	26.02M	25.46M	24.51M	23.38M	22.66M	21.58M	21.3M	20.33M	19.96M	19.6M	21.94M
Research & Development	2.71M	2.63M	5.84M	5.92M	5.73M	5.89M	2.86M	2.81M	2.85M	2.55M	2.28M	2.17M	2.16M	1.95M	1.91M	1.92M	1.92M	1.95M
Other Expenses	n/a	n/a	495.15K	495.15K	495.15K	495.15K	n/a	n/a	n/a	13.1K	-1.81K	2.12K	9.26K	9.35K	18.61K	28.18K	30.39K	35.05K
Operating Expenses	35.94M	35.16M	34.39M	33.68M	32.21M	31.05M	30.12M	28.84M	28.31M	27.06M	25.65M	24.83M	23.74M	23.25M	22.23M	21.88M	21.52M	23.89M
Interest Expense	n/a	n/a	n/a	342.41K	342.41K	342.41K	342.41K	n/a	n/a	n/a	14.91K	14.91K	14.91K	14.91K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	16.5M	15.97M	15.62M	14.43M	13.5M	12.8M	11.97M	12.31M	12.48M	12.61M	12.68M	12.14M	11.68M	11.25M	10.56M	10.5M	10.2M	10.1M
Cost & Expenses	53.83M	52.51M	51.28M	49.98M	48.04M	46.91M	45.53M	43.84M	42.52M	39.91M	37.68M	35.83M	34.37M	33.79M	32M	31.13M	30.22M	31.98M
Income Tax Expense	5.38M	5.19M	5.04M	4.99M	4.96M	4.71M	4.55M	4.43M	3.9M	3.72M	3.35M	1.54M	1.25M	699.62K	510.82K	1.32M	518.8K	-667.91K
Shares Outstanding (Basic)	12.72M	12.71M	12.68M	12.67M	12.66M	12.66M	12.62M	12.6M	12.6M	12.62M	12.57M	12.56M	12.56M	12.55M	12.43M	12.33M	12.31M	12.31M
Shares Outstanding (Diluted)	12.83M	12.83M	12.78M	12.78M	12.76M	12.75M	12.74M	12.74M	12.72M	12.69M	12.63M	12.63M	12.63M	12.66M	12.63M	12.6M	12.55M	12.52M
EPS (Basic)	1.63	1.57	1.53	1.48	1.48	1.42	1.36	1.29	1.16	1.09	1.02	1.04	0.98	0.84	0.75	0.49	0.37	0.08
EPS (Diluted)	1.62	1.55	1.50	1.46	1.46	1.41	1.36	1.29	1.16	1.09	1.02	1.04	0.97	0.83	0.74	0.48	0.37	0.08
EBITDA	24.74M	23.58M	23.42M	22.77M	22.89M	22.41M	21.13M	19.67M	18.33M	17.84M	17.16M	16.23M	15.09M	12.62M	11.22M	8.72M	6.41M	1.61M
EBIT	16.4M	22.67M	21.96M	22.98M	23.6M	22.63M	21.4M	19.97M	17.8M	16.68M	15.73M	14.59M	13.45M	11.12M	9.84M	7.39M	5.09M	300.88K
Depreciation & Amortization	586.56K	785.69K	817.66K	828.17K	820.43K	808.65K	765.12K	734.55K	712.35K	693.1K	670.67K	657.11K	646.28K	640.88K	634.01K	811.77K	985.96K	1.15M